Massive Bio has been named a Best in Class Quarterfinalist in the AI in Patient Care category of the Digital Health Hub Foundation Awards 2025. This acknowledgement places Massive Bio among a select group of organizations driving digital innovation to improve patient outcomes.
The AI in Patient Care category focuses on solutions that apply artificial intelligence to directly support patients, making care more accessible, efficient, and effective. Massive Bio’s selection reflects its work in AI-powered clinical trial matching, which helps patients find and enroll in clinical trials faster while reducing the administrative burden on physicians and research teams.
Clinical trial enrollment has long been one of the most significant challenges in oncology research. Traditional recruitment methods often leave patients without access to potentially life-changing studies, while trial sites face bottlenecks and inefficiencies. By leveraging AI, Massive Bio enables more patients to be identified and connected to appropriate trials at scale, ensuring broader access and accelerating the research process.
The Digital Health Hub Foundation will announce finalists on October 4, 2025, with winners to be revealed live at HLTH USA in Las Vegas on October 20, 2025.
Massive Bio is proud to stand alongside other innovators recognized in this year’s awards. Together, these efforts signal how digital health is reshaping the future of clinical research and patient care.
